Johnson & Johnson Development Corporation
Venture capital · New Brunswick, New Jersey, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
6Deep-tech portfolio2 active
4Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: Grail
8Co-investorsShare a portfolio company
Portfolio · 6 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Cour Pharmaceutical | Biotech | Active | — | — |
| Numab Therapeutics | Biotech | Active | — | — |
| Grail | Medtech | Public | Nov 7, 2025 | $1.7B |
| Tmunity Therapeutics | Biotech | Acquired | Oct 30, 2019 | $140.0M |
| Armo Biosciences | Biotech | Acquired | — | — |
| Proteovant Therapeutics | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#67
Portfolio exits#49
Raises, 12 months#22
Co-investors#173
Co-investors
- Amgen VenturesVenture capital1 shared
- Breakthrough Energy VenturesVenture capital1 shared
- Bristol-Myers SquibbVenture capital1 shared
- Gilead SciencesVenture capital1 shared
- IlluminaVenture capital1 shared
- Johnson & Johnson Robotics and Digital SolutionsVenture capital1 shared
- Roivant SciencesVenture capital1 shared
- Third Rock VenturesVenture capital1 shared
Sectors
- Biotech5
- Medtech1
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.